This is the text extract for March Tender Notification, browse documents here.

---

31 March 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products included in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th April 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 May 2010, reference pricing of non-tender winning brand will occur on 1 July 2010 and Sole Subsidised Supply commences on 1 October 2010.

The decisions were as follows:

Chemical Name Bendrofluazide Bendrofluazide

Presentation; Pack size and type Tab 2.5 mg; 500 tablets, bottle Tab 5 mg; 500 tablets, bottle

Current New Subsidy tender and price subsidy $13.50 $21.50 $7.58 $11.75

Sole supply brand (Supplier) Arrow-Bendrofluazide (Arrow) Arrow-Bendrofluazide (Arrow)

Brands affected by reference pricing and delisting Neo-Naclex (GSK) Neo-Naclex (GSK)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 May 2010 and DV Limits and DV Pharmaceuticals will apply from 1 July 2010.

The decisions were as follows:

Chemical Name Bendrofluazide Bendrofluazide

Presentation; Pack size and type Tab 2.5 mg; 500 tablets, bottle Tab 5 mg; 500 tablets, bottle

Hospital Supply Brand (Supplier) Arrow-Bendrofluazide (Arrow) Arrow-Bendrofluazide (Arrow)

Pack Price $7.58 $11.75

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Neo-Naclex (GSK) Neo-Naclex (GSK)

A338258 - qA15909

---

2009/10 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 May 2010 and Sole Supply Status commences 1 August 2010.

The decisions were as follows:

Chemical Name Lamivudine Lamivudine

Presentation; Pack size and type Oral liq 10 mg per ml; 240 ml OP, bottle Tab 150 mg; 60 tablets, bottle

Current Subsidy $100.00 $307.20

New tender subsidy $50.00 $153.60

Sole supply brand (Supplier) 3TC (GSK NZ) 3TC (GSK NZ)

4. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 July 2010 and Sole Supply Status commences 1 October 2010, unless otherwise stated.

The decisions were as follows:

Chemical Name Aspirin Aspirin Cetomacrogol Clotrimazole Clotrimazole Dextrose with electrolytes Dextrose with electrolytes Dextrose with electrolytes Fluoxetine hydrochloride** Fluoxetine hydrochloride Fusidic acid Fusidic acid

Presentation; Pack size and type Tab 100 mg; 990 tablets, blister Tab dispersible 300 mg; 100 tablets, blister Crm BP; 500 g, pot Vaginal crm 1% with applicator; 35 g OP, tube Vaginal crm 2% with applicator; 20 g OP, tube Soln with electrolytes; 1,000 ml OP, bottle

Current Subsidy $16.83 $2.15 $3.50 $1.45 $2.75 $6.66

New tender subsidy $14.00 $2.00 $3.15 $1.30 $2.50 $6.60

Sole supply brand (Supplier) Ethics Aspirin EC (Multichem) Ethics Aspirin (Multichem) PSM (API Consumer) Clomazol (Multichem) Clomazol (Multichem) Pedialyte – Fruit (Abbott Nutrition) Pedialyte - Bubblegum (Abbott Nutrition) Pedialyte – Plain Fluox (Mylan) Fluox (Mylan) Foban (AFT) Foban (AFT) Micreme H (Mylan) Fenpaed (AFT) Lorapaed (AFT) Loraclear Hayfever Relief (AFT) A-Lices (AFT) Dr Reddy's Pantoprazole (Dr Reddy’s) Dr Reddy's Pantoprazole (Dr Reddy’s) Loxamine (Mylan)

Soln with electrolytes; 1,000 ml OP, bottle Soln with electrolytes; 1,000 ml OP, bottle Cap 20 mg; 84 tablets, blister Tab dispersible 20 mg, scored; 30 tablets, blister Crm 2%; 15 g OP, tube Oint 2 %; 15 g OP, tube

$6.66 $6.78 $4.39 (90 tablets) $5.50 $3.95 $3.95 $2.20 $3.49 $3.65 $3.58 $2.83 $2.24

$6.60 $6.75 $2.70 $2.50 $3.25 $3.25 $2.10 $2.69 $3.10 $2.09 $2.83 $1.23

Hydrocortisone with Crm 1% with miconazole nitrate 2%; 15 g OP, miconazole tube Ibuprofen Loratadine Loratadine Malathion Pantoprazole Oral liq 100 mg per 5 ml; 200 ml, bottle Oral liq 1 mg per ml; 100 ml, bottle Tab 10 mg; 100 tablets, blister Shampoo 1%; 30 ml OP, bottle Tab 20 mg; 28 tablets, blister

Pantoprazole Paroxetine hydrochloride

Tab 40 mg; 28 tablets, blister Tab 20 mg; 30 tablets, blister

$3.36 $5.90

$1.54 $2.38

A338258 - qA15909

Page 2 of 5

---

Chemical Name Ropinirole hydrochloride Ropinirole hydrochloride Ropinirole hydrochloride Ropinirole hydrochloride Spironolactone Spironolactone

Presentation; Pack size and type Tab 0.25 mg; 84 tablets, bottle Tab 1 mg; 84 tablets, bottle Tab 2 mg; 84 tablets, bottle Tab 5 mg; 84 tablets, bottle Tab 25 mg; 100 tablets, bottle Tab 100 mg; 100 tablets, bottle

Current Subsidy $7.90 $40.32 $60.72 $90.00 $8.50 $21.70

New tender subsidy $6.20 $15.95 $24.95 $38.00 $4.60 $15.15

Sole supply brand (Supplier) Ropin (Mylan) Ropin (Mylan) Ropin (Mylan) Ropin (Mylan) Spirotone (Mylan) Spirotone (Mylan)

**The 90 tablet pack of Fluox will be reference priced to the 84 tablet pack from 1 September 2010 and the 90 tablet pack will be delisted from 1 December 2010.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 5. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 July 2010; DV Limits and DV Pharmaceuticals will apply from 1 September 2010

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Vaginal crm 1% with applicators; 35 g, tube

Hospital Supply Brand (Supplier) Clomazol (Multichem)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) Canesten (Bayer) Clocreme (Mylan) Clotrimaderm (AFT) Canesten (Bayer) Clocreme (Mylan) Clotrimaderm (AFT) Flexetor (Novartis) Dr Reddy’s (Dr Reddy’s) Prozac (Eli Lilly) (B) Fucidin (CSL) Fucidin (CSL) Gemzar (Eli Lilly) Hospira (Hospira) Gemzar (Eli Lilly) Hospira (Hospira) Nurofen (Reckitt Benckiser) Claratyne (ScheringPlough) Lorfast (Multichem) Apo-Loratadine (Apotex) Aridine (Douglas) Arrow-Loratadine (Arrow) Claratyne (Schering-Plough)

Clotrimazole

$1.30

1%

Clotrimazole

Vaginal crm 2% with applicators; 20 g, tube

Clomazol (Multichem)

$2.50

1%

Fluoxetine hydrochloride** Fluoxetine hydrochloride Fusidic acid Fusidic acid Gemcitabine hydrochloride*** Gemcitabine hydrochloride*** Ibuprofen

Cap 20 mg; 84 tablets, blister Tab dispersible 20 mg, scored; 30 tablets, blister Crm 2%; 15 g, tube Oint 2 %; 15 g, tube Inj 200 mg; 1 injection, vial

Fluox (Mylan)

$2.70

1%

Fluox (Mylan) Foban (AFT) Foban (AFT) Gemcitabine Ebewe (InterPharma) Gemcitabine Ebewe (InterPharma) Fenpaed (AFT)

$2.50 $3.25 $3.25 $12.50

1% 1% 1% 1%

Inj 1 g; 1 inejction, vial Oral liq 100 mg per 5 ml; 200 ml, bottle Oral liq 1 mg per ml; 100 ml, bottle

$62.50

1%

$2.69

1%

Loratadine

Lorapaed (AFT)

$3.10

1%

Loratadine

Tab 10 mg; 100 tablets, blister

Loraclear Hayfever Relief (AFT)

$2.09

1%

A338258 - qA15909

Page 3 of 5

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) Lorastyne (Schering-Plough) Lora-tabs (Pacific) Lorfast (Multichem) Tirlor (Novartis) Onkotrone (Baxter)

Mitozantrone˜

Inj 2 mg per ml, 10 ml; 1 injection, vial

Mitozantrone Ebewe $100.00 (InterPharma) Dr Reddy's Pantoprazole (Dr Reddy’s) Dr Reddy's Pantoprazole (Dr Reddy’s)

1%

Pantoprazole

Tab 20 mg; 28 tablets, blister

$1.23

1%

Somac (Mylan)

Pantoprazole

Tab 40 mg; 28 tablets, blister

$1.54

1%

Somac (Mylan) AFT (AFT) Aropax (GSK) Arrow-Paroxetine (Arrow) Requip (GSK) Requip (GSK) Requip (GSK) Requip (GSK) (B) (B)

Paroxetine hydrochloride Ropinirole hydrochloride Ropinirole hydrochloride Ropinirole hydrochloride Ropinirole hydrochloride Spironolactone Spironolactone

Tab 20 mg; 30 tablets, blister

Loxamine (Mylan)

$2.38

1%

Tab 0.25 mg; 84 tablets, bottle Tab 1 mg; 84 tablets, bottle Tab 2 mg; 84 tablets, bottle Tab 5 mg; 84 tablets, bottle Tab 25 mg; 100 tablets, bottle Tab 100 mg; 100 tablets, bottle

Ropin (Mylan) Ropin (Mylan) Ropin (Mylan) Ropin (Mylan) Spirotone (Mylan) Spirotone (Mylan)

$6.20 $15.95 $24.95 $38.00 $4.60 $15.15

1% 1% 1% 1% 1% 1%

**The 90 tablet pack of Fluox will be delisted from 1 September 2010. *** The subsidy of gemcitabine hydrochloride inj 1 mg for ECP will reduce from $0.26 per 1 mg to $0.12 per 1 mg from 1 July 2010 in Section B of the Pharmaceutical Schedule.

˜The subsidy of mitozantrone inj for ECP will reduce from $12.43 per 1 mg to $5.65 per 1 mg from 1 July 2010 in Section B of the

Pharmaceutical Schedule.

6. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price change for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 May 2010; DV Limits and DV pharmaceuticals will apply from 1 July 2010; delisting of the other brand in Section H will occur on 1 July 2010.

The decisions were as follows:

Chemical Name Cisplatin* Cisplatin*

Presentation; Pack size and type Inj 1 mg per ml, 50 ml; 1 injection, vial Inj 1 mg per ml, 100 ml; injection, vial

Hospital Supply Brand (Supplier) Cisplatin Ebewe (InterPharma) Cisplatin Ebewe (InterPharma)

Pack Price $15.00 $21.00

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) DBL Cisplatin (Hospira) DBL Cisplatin (Hospira)

*The subsidy of cisplatin inj 1 mg for ECP will reduce from $0.46 per 1 mg to $0.24 per 1 mg from 1 July 2010 in Section B of the Pharmaceutical Schedule.

7. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 May 2010 and DV Limits and DV Pharmaceuticals will apply from 1 July 2010.

The decisions were as follows:

A338258 - qA15909

Page 4 of 5

---

Chemical Name Tenoxicam

Presentation; Pack size and type Inj 20 mg; 1 injection, vial

Hospital Supply Brand (Supplier) AFT (AFT)

Pack Price $9.95

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) (B)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 4 December 2009.

The decisions were as follows:

Chemical Name Acebutolol Acebutolol Acebutolol Busulphan Busulphan Busulphan Cisplatin Famotidine Famotidine Indomethacin Indomethacin Indomethacin Indomethacin Lamivudine Lomustine Lomustine Mitomycin C Mitomycin C Nizatidine Nizatidine Orphenadrine Citrate Prazosin Hydrochloride Prazosin Hydrochloride Prazosin Hydrochloride Rabeprazole Rabeprazole Risedronate Sodium Risedronate Sodium Risedronate Sodium Risedronate Sodium

Line Item Cap 100 mg Cap 200 mg Tab 400 mg Tab 2 mg Tab 25 mg Tab 50 mg Inj 10 mg Tab 20 mg Tab 40 mg Cap 50 mg Cap 25 mg Suppos 100 mg Cap long-acting 75 mg Tab 100 mg Cap 10 mg Cap 40 mg Inj 2 mg Inj 10 mg Cap 150 mg Cap 300 mg Tab 100 mg Tab 1 mg Tab 2 mg Tab 5 mg Tab 10 mg Tab 20 mg Tab 5 mg Tab 30 mg Tab 35 mg Tab 150 mg

For the remaining products on the Invitation to Tender dated 21 December 2007, the Invitation to Tender dated 23 December 2008 and the Invitation to Tender dated 4 December 2009 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A338258 - qA15909

Page 5 of 5